Preclinical development of a chimeric antigen receptor T cell therapy targeting FGFR4 in rhabdomyosarcoma
Cell Rep Med
.
2024 May 21;5(5):101586.
doi: 10.1016/j.xcrm.2024.101586.
Epub 2024 May 9.
Authors
Meijie Tian
,
Jun S Wei
,
Nityashree Shivaprasad
,
Steven L Highfill
,
Berkley E Gryder
,
David Milewski
,
G Tom Brown
,
Larry Moses
,
Hannah Song
,
Jerry T Wu
,
Peter Azorsa
,
Jeetendra Kumar
,
Dina Schneider
,
Hsien-Chao Chou
,
Young K Song
,
Abdelrahman Rahmy
,
Katherine E Masih
,
Yong Yean Kim
,
Brian Belyea
,
Corinne M Linardic
,
Boro Dropulic
,
Peter M Sullivan
,
Poul H Sorensen
,
Dimiter S Dimitrov
,
John M Maris
,
Crystal L Mackall
,
Rimas J Orentas
,
Adam T Cheuk
,
Javed Khan
PMID:
38723625
DOI:
10.1016/j.xcrm.2024.101586
No abstract available
Publication types
Published Erratum